CLINICAL STUDIES OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF LIVE MONOVALENT INFLUENZA VACCINE (STRAIN А/17/CALIFORNIA/2009/38 — H1N1) IN CHILDREN

CLINICAL STUDIES OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF LIVE MONOVALENT INFLUENZA VACCINE (STRAIN А/17/CALIFORNIA/2009/38 — H1N1) IN CHILDREN

Show other versions (1)

<em>Results of performed pre-clinical and clinical studies with volunteers 18-60 years old allowed registration of vaccine «INFLUVIR» (live monovalent vaccine for the prophylaxis of influenza A/H1N1, strain A/17/California/2009/38 (H1N1), developed by NPO «Microgen» in Russian Federation so ti...

Full description

Bibliographic Details
Main Authors: D.S. Bushmenkov, A.N. Mironov, A.A. Romanova, A.A. Tsaan, I.V. Feldblyum
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2010-01-01
Series:Voprosy Sovremennoj Pediatrii
Online Access:http://vsp.spr-journal.ru:80/jour/article/view/926

Similar Items

Similar Items